✦ LIBER ✦

Dapagliflozin Added to Usual Care in Individuals with Type 2 Diabetes Mellitus with Preexisting Cardiovascular Disease: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study with a 28-Week Extension

✍ Scribed by Leiter, Lawrence A.; Cefalu, William T.; de Bruin, Tjerk W. A.; Gause-Nilsson, Ingrid; Sugg, Jennifer; Parikh, Shamik J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dapagliflozin add-on to metformin in typ

✍ Clifford J Bailey, Jorge L Gross, Delphine Hennicken, Nayyar Iqbal… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 827 KB

Dapagliflozin Is Effective as Add-on The

✍ Jabbour, S. A.; Hardy, E.; Sugg, J.; Parikh,, S. 📂 Article 📅 2013 🏛 American Diabetes Association 🌐 English ⚖ 737 KB

Effect of dapagliflozin in patients with

✍ K. Strojek; K. H. Yoon; V. Hruba; M. Elze; A. M. Langkilde; S. Parikh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 662 KB

Manidipine versus enalapril monotherapy

✍ Manuel Luque Otero; Nieves Marte Claros 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 828 KB

Effect of exenatide on 24-hour blood glu

✍ Sherwyn L. Schwartz; Robert E. Ratner; Dennis D. Kim; Yongming Qu; Linda L. Fech 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 230 KB

Efficacy and safety of canagliflozin mon

✍ Inagaki, Nobuya; Kondo, Kazuoki; Yoshinari, Toru; Takahashi, Nahoko; Susuta, Yut 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 708 KB